| 落实《药品不良反应报告和监测管理办法》浅议 |
| |
| 引用本文： | 张万新. 落实《药品不良反应报告和监测管理办法》浅议[J]. 中国药事, 2012, 26(2): 157-158 |
| |
| 作者姓名： | 张万新 |
| |
| 作者单位： | 湖南省长沙市食品药品监督管理局,长沙,410005 |
| |
| 摘 要： | 目的 推进药品不良反应报告和监测管理工作顺利开展.方法 梳理药品不良反应报告和监测管理工作实践,分析存在的问题.结果与结论 药品不良反应报告和监测管理工作仍然存在一些尚待完善之处,笔者就此提出了一些具体的建议.
|
| 关 键 词： | 药品不良反应 报告 监测 |
Discussion on How to Execute the Practice of Reporting and Supervision of ADR |
| |
| Zhang Wanxin. Discussion on How to Execute the Practice of Reporting and Supervision of ADR[J]. Chinese Pharmaceutical Affairs, 2012, 26(2): 157-158 |
| |
| Authors: | Zhang Wanxin |
| |
| Affiliation: | Zhang Wanxin(Changsha Food and Drug Administration,Hunan Province,Changsha 410005) |
| |
| Abstract: | Objective To carry out the works of monitoring and reporting of ADRs effectively.Methods Analyze and summarize existing problems on the current status of supervision and reporting of ADR.Results and Conclusion There were still many problems existing in current reporting of ADR and supervision.Some personal opinions and suggestions on how to solve those problems were presented in this article. |
| |
| Keywords: | ADR reporting supervision |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
